跳至主要内容
临床试验/ISRCTN25761503
ISRCTN25761503已完成未知

Primary prophylaxis with ciprofloxacin improves survival and reduces bacterial infections in patients with cirrhosis and ascites

The Health Council of Investigation of the Government of Buenos Aires (Argentina)0 个研究点目标入组 100 人开始时间: 2007年2月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

2008 results in: https://www.ncbi.nlm.nih.gov/pubmed/18316137 (added 09/05/2019)

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diagnosis of cirrhosis was based in clinical, biochemical, ultrasonographic and histological criteria.
  • Inclusion criteria were:
  • 1. Aged more than 18 and less than 80 years
  • 2. Total protein in ascitic fluid less than 1.5 g/dl
  • 3. Ability to give written informed consent

排除标准

  • 1. A previous episode of SBP
  • 2. Antibiotics in the previous 30 days
  • 3. Pregnancy
  • 4. Active gastrointestinal bleeding
  • 5. Encephalopathy more than grade two
  • 6. Hepatocarcinoma or other malignancies
  • 7. Allergy to quinolones
  • 8. Serum creatinine more than 3 mg/dl
  • 9. Bacterial infection

研究者

发起方
The Health Council of Investigation of the Government of Buenos Aires (Argentina)

相似试验